Correlation Between Equillium and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Equillium and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Equillium and AN2 Therapeutics, you can compare the effects of market volatilities on Equillium and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and AN2 Therapeutics.
Diversification Opportunities for Equillium and AN2 Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Equillium and AN2 is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Equillium i.e., Equillium and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Equillium and AN2 Therapeutics
Allowing for the 90-day total investment horizon Equillium is expected to generate 0.91 times more return on investment than AN2 Therapeutics. However, Equillium is 1.1 times less risky than AN2 Therapeutics. It trades about 0.03 of its potential returns per unit of risk. AN2 Therapeutics is currently generating about 0.02 per unit of risk. If you would invest 72.00 in Equillium on September 13, 2024 and sell it today you would lose (2.00) from holding Equillium or give up 2.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Equillium vs. AN2 Therapeutics
Performance |
| Timeline |
| Equillium |
| AN2 Therapeutics |
Equillium and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Equillium and AN2 Therapeutics
The main advantage of trading using opposite Equillium and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Equillium vs. Lyra Therapeutics | Equillium vs. Hookipa Pharma | Equillium vs. Jasper Therapeutics | Equillium vs. Cingulate Warrants |
| AN2 Therapeutics vs. Puma Biotechnology | AN2 Therapeutics vs. Iovance Biotherapeutics | AN2 Therapeutics vs. Sarepta Therapeutics | AN2 Therapeutics vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |